BP Amoco PLC
30 March 2000
LETTER TO: COMPANY ANNOUNCEMENTS OFFICE
We write to notify you:-
* we were advised on 30 March that the following Directors of BP Amoco p.l.c.
received the numbers of BP Amoco ADSs shown opposite their names on 29 March
2000 @ $51.2663 per ADS under the Company's dividend reinvestment plan:-
Mrs R.S. Block 47.9069 ADSs
(equivalent to approx 288 Ordinary shares)
Mr E.B. Davis 33.1918 ADSs
(equivalent to approx 199 Ordinary shares)
Dr W.E. Massey 25.3448 ADSs
(equivalent to approx 152 Ordinary shares)
Mr C.F. Knight 28.0789 ADSs
(equivalent to approx 168 Ordinary shares)
* we were advised on 29 March that the following Directors of BP Amoco p.l.c.
acquired the numbers of BP Amoco Ordinary shares shown opposite their names on
24 March 2000 @ £5.423 per share under the Company's dividend reinvestment
plan:-
Dr J.G.S. Buchanan 1,743 Ordinary shares
Mr R.F. Chase 1,670 Ordinary shares
Sir Robin Nicholson 20 Ordinary shares
* we were advised on 29 March that the following Directors of BP Amoco p.l.c.
acquired the number of BP Amoco Ordinary shares shown opposite their names on 24
March 2000 @ £5.43 per share through reinvestment of PEP/ISA dividends:-
Dr J.G.S. Buchanan 28 Ordinary shares
Mr R.L. Olver 77 Ordinary shares
Mr B.K. Sanderson 77 Ordinary shares
From: J Bowes (Company Secretary's Office)
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.